作者: Johan Immunologie et Chimie Thérapeurique Hoebeke , Richard Casimir , David Chauvier
DOI:
关键词:
摘要: The invention relates to peptides having a core sequence selected in the group comprising: SEQ ID N°1: VDEAD, N°2: LDEGD, N°3: VDEGD, N°4: VDESD, N°5: LDEKD, N°6: FDESD, N°7: LDEAD, application as inhibitors of caspase-2 and/or -6 activity.